1MRKX:BIT
Merck & Co Inc
€128.18
arrow_downward
-0.59%(-0.76) 1நா
அக். 2, 5:26:00 PM GMT+2 · EUR
search
அனைத்துக் குறியீடுகளும்
| குறியீடு | விலை | மாற்றம் | % மாற்றம் |
|---|
செய்திக் கட்டுரைகள்
இணைய ஆவணங்கள் மற்றும் செய்திப் பார்ட்னர்களிடமிருந்து
Yahoo Finance
·
1 மணிநேரம் முன்
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
MarketBeat
·
1 மணிநேரம் முன்
9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc
TipRanks
·
1 மணிநேரம் முன்
Merck appoints Paul Diaz to its board of directors
The Pharma Letter
·
3 மணிநேரம் முன்
Nimbus hires Merck & Co dealmaker as chief business officer
சுயவிவரம்
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia